Comparison of the Effects of Pioglitazone versus Placebo when Given in Addition to Standard Insulin Treatment in Patients with Type 2 Diabetes Mellitus Requiring Hemodialysis: Results from the PIOren Study

Publisher： Karger

E-ISSN： 1664-5529|2|1|104-114

ISSN： 1664-5529

Source： Nephron Extra, Vol.2, Iss.1, 2012-05, pp. : 104-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fibrinolysis Defect in Long-Term Hemodialysis Patients with Type 2 Diabetes mellitus and Its Relation to Metabolic Disorders

By  

American Journal of Nephrology, Vol. 22, Iss. 5-6, 2002-10 ,pp. : 429-436

Karger

Access to resources Recommend Favorite

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study

By  

American Journal of Nephrology, Vol. 45, Iss. 2, 2016-12 ,pp. : 136-145

Karger

Access to resources Recommend Favorite

G-Protein β3 Subunit C825T Variant, Nephropathy and Hypertension in Patients with Type 2 (Non-Insulin-Dependent) Diabetes mellitus

By  

American Journal of Nephrology, Vol. 20, Iss. 4, 2000-09 ,pp. : 305-310

Karger

Access to resources Recommend Favorite

Left Ventricular Hypertrophy in Incident Dialysis Patients Randomized to Treatment with Hemofiltration or Hemodialysis: Results from the ProFil Study

By  

Blood Purification, Vol. 32, Iss. 1, 2011-01 ,pp. : 21-29

Karger

Access to resources Recommend Favorite

Recent Advances in the Treatment of Atherogenic Dyslipidemia in Type 2 Diabetes Mellitus

By  

Kidney and Blood Pressure Research, Vol. 34, Iss. 4, 2011-06 ,pp. : 209-217

Karger

Access to resources Recommend Favorite